13FXENON PHARMACEUTICALS INC (XENE)
6 tracked managers currently hold XENE on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | ADD | $99.2M | 0.1 % | 0.0 % | 1,642,848 | +1,036,763 |
| CITADEL ADVISORS LLC | Q2 2026 | TRIM | $84.6M | 0.0 % | 0.1 % | 1,401,242 | -1,251,748 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | ADD | $22.7M | 0.0 % | 0.0 % | 376,777 | +174,992 |
| Duquesne Family Office LLC | Q2 2026 | HELD | $14.4M | 0.3 % | 0.5 % | 238,600 | 0 |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $13.5M | 0.0 % | 0.0 % | 223,922 | +204,982 |
| Point72 Asset Management, L.P. | Q2 2026 | NEW | $7.9M | 0.0 % | — | 130,378 | NEW |